Boehringer IngelheimIngelheim, GermanyOpen the interactive map Boehringer Ingelheim
BI X (Synapse)
Ingelheim, Germany
About Boehringer Ingelheim
Boehringer Ingelheim is a German pharmaceutical company developing human and animal health medicines.
How Boehringer Ingelheim works with startups
BI X is Boehringer Ingelheim's digital innovation lab, running the Synapse program where startups, scale-ups and research groups co-create and validate digital solutions with BI stakeholders. Synapse gives external partners access to funding to test and implement pilot projects inside Boehringer Ingelheim's organization. Engagement runs through ideation support, joint refinement and a path to internal impact.
Source: www.bix-digital.com
Areas of interest
- Digital Health
- AI & Data Analytics
- Digital Twins & Simulation
Open calls
Standing invitation for startups/scale-ups to apply to BI X's Synapse co-creation program
Check current availability ↗Help keep this profile accurate
Represent this team, or spotted something that changed? Open the map profile to suggest a correction, request verification or report a removal. Submissions are reviewed before publication.